<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://regulatorynews.com/neurora-autism-diagnostic-evidence-gap</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T10:49:28-04:00</news:publication_date>
      <news:title>FDA Clears Neurora AI Tool for Autism Diagnosis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/leads-biolabs-opamtistomig-fast-track-biliary</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T09:37:45-04:00</news:publication_date>
      <news:title>Leads Biolabs Wins Second FDA Fast Track for BTC Drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/rougetx-rtx-001-series-a-financing</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T09:37:45-04:00</news:publication_date>
      <news:title>RougeTx Raises $58 Million Series A for HHT Drug RTX-001</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/vantis-vascular-crossfast-6f-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T09:37:45-04:00</news:publication_date>
      <news:title>Vantis Vascular Wins FDA Clearance for 6F CrossFAST</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/who-device-prequalification-expansion</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T06:00:41-04:00</news:publication_date>
      <news:title>WHO Expands Device Prequalification to Condoms, IUDs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-mdufa-fy2027-fee-rates</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T05:55:15-04:00</news:publication_date>
      <news:title>FDA Raises Device User Fees About 10% for FY2027</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/mhra-onswik-uk-authorisation</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T05:55:15-04:00</news:publication_date>
      <news:title>MHRA Authorises Lilly&apos;s Weekly Insulin Onswik</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/abbott-cardiomems-dynamic-treatment-plan-app</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T10:52:40-04:00</news:publication_date>
      <news:title>FDA Clears Patient App for Abbott&apos;s CardioMEMS Monitor</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/novartis-rhapsido-dermographism-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T09:52:51-04:00</news:publication_date>
      <news:title>Novartis Earns FDA Nod for First Dermographism Drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/icotec-cmore-ct-cms-reimbursement</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T09:41:50-04:00</news:publication_date>
      <news:title>icotec Wins Medicare Add-On Payment for CMORE CT</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/retension-pharmaceuticals-ipo-financing</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T09:41:50-04:00</news:publication_date>
      <news:title>Retension Pharmaceuticals Prices $45M Nasdaq IPO</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/abbvie-temab-a-breakthrough-designations</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T06:06:20-04:00</news:publication_date>
      <news:title>AbbVie&apos;s Temab-A Wins Two FDA Breakthrough Tags</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/okami-lobo-venous-indication-expansion</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T06:06:20-04:00</news:publication_date>
      <news:title>FDA Expands Okami&apos;s LOBO Occluder to Veins</news:title>
    </news:news>
  </url>
</urlset>
